Abstract
Lymph node status is one of the decisive prognostic factors in breast cancer. Chemotherapy targeting regional lymphatic tissues has emerged as a promising therapy for the treatment of malignancies with a high tendency to disseminate lymphatically. The present study determined the drug concentrations in axillary lymph nodes after lymphatic chemotherapy (LC) in patients with breast cancer and compared the results with those receiving intravenous chemotherapy (VC) to investigate whether LC could improve the accumulation of anticancer drug in regional lymph nodes. Sixty patients with breast carcinoma confirmed by preoperative puncture-biopsy were divided into two groups at random. The LC group (n = 30) received a subcutaneous injection of 4 ml of carboplatin-activated carbon suspension, containing 20 mg of carboplatin, adjacent to the primary tumour. The VC group (n = 30) received an intravenous administration of an equal dose of aqueous carboplatin. At 1, 12, 24, 36 and 48 hours after administration, modified radical mammectomies were performed on 12 patients at each time point, with 6 from each group. Axillary lymph nodes were removed for pathological examination. The platinum concentrations in nodes were determined by Zeeman ato...Continue Reading
References
Jul 15, 1983·International Journal of Cancer. Journal International Du Cancer·H T RupniakB T Hill
Jul 1, 1995·World Journal of Surgery·T TakahashiT Yamaguchi
Jun 1, 1994·Japanese Journal of Cancer Research : Gann·Y AkamoJ Yura
Aug 10, 2000·The British Journal of Surgery·L JansenO E Nieweg
Feb 28, 2001·Fresenius' Journal of Analytical Chemistry·J M Meerum TerwogtJ H Beijnen
Aug 8, 2001·Advanced Drug Delivery Reviews·C Oussoren, G Storm
May 2, 2002·Anti-cancer Drugs·Yunning HuangYuzhuo Fan
Apr 8, 2004·Clinical Nuclear Medicine·A ErogluS Cantez
Citations
Apr 1, 2009·Nanomedicine·Feng YangDeliang Fu
Sep 6, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Qian YangQing Lv
Mar 15, 2014·Journal of Drug Targeting·Rong TanNianping Feng
Apr 13, 2005·Journal of Drug Targeting·Rui LingJianghao Chen
Jun 13, 2015·Science Translational Medicine·Bonnie HuangDarrell J Irvine
Jun 24, 2016·World Journal of Surgical Oncology·Junze DuJun Jiang
Apr 27, 2016·Thoracic Surgery Clinics·Christopher S DigesuYolonda L Colson
Feb 1, 2012·The Journal of International Medical Research·F GuoZ Wang
Feb 2, 2018·Journal of Drug Targeting·John C KraftRodney J Y Ho
Dec 21, 2007·Nuclear Medicine Communications·Ling WangJianghao Chen
Apr 5, 2019·Cancer Immunology, Immunotherapy : CII·Jossie RotmanTanja D de Gruijl
Mar 14, 2014·Pharmaceutical Research·João G MarquesIlídio J Correia
Jun 6, 2020·Immunological Investigations·Booyeon J HanScott A Gerber
May 27, 2015·Medical Oncology·Jianghao ChenLing Wang
Nov 22, 2018·Breast Cancer Research : BCR·Gaurav ChatterjeeAnita Grigoriadis
Mar 13, 2018·Frontiers in Oncology·Dennis JonesTimothy P Padera
Aug 29, 2019·Advanced Drug Delivery Reviews·Brianna CoteAdam W G Alani
Jan 5, 2021·Nano Today·Liwei JiangReza Abdi
May 8, 2021·Experimental Biology and Medicine·Noah Trac, Eun Ji Chung
Sep 7, 2021·Medicinal Research Reviews·Sara RezzolaRoberto Ronca
Jan 10, 2012·Journal of the American College of Surgeons·Onkar V KhullarYolonda L Colson